Latest Articles

Publication Date
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology

Published: Jan. 11, 2026, 4:14 p.m.
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ETPharma.com

AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty ETPharma.com

Published: Jan. 10, 2026, 1:55 a.m.
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ET Pharma

AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty ET Pharma

Published: Jan. 10, 2026, 1:55 a.m.
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology

Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology

Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology

Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology

Published: Jan. 5, 2026, 1:12 p.m.
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy - Targeted Oncology

Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy Targeted Oncology

Published: Jan. 5, 2026, 1:07 p.m.
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer - Targeted Oncology

Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer Targeted Oncology

Published: Dec. 23, 2025, 2:07 p.m.
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology

Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology

Published: Dec. 22, 2025, 1:15 p.m.
Fluorescence-Guided Bladder and Ureter Visualization in Benign Robotic Gynecologic Surgery: A Series of Five Cases.

Indocyanine green (ICG) near-infrared fluorescence imaging is well established in gynecologic oncology, but its role in benign minimally invasive surgery is still limited and not standardized. Increasing cesarean section and …

Published: Dec. 9, 2025, midnight
AI-Driven Advances in Women's Health Diagnostics: Current Applications and Future Directions.

Background: Women's health has historically served as an incubator for major medical innovations yet often faces relative neglect in sustained funding and implementation. The rise of artificial intelligence (AI) and …

Published: Dec. 3, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!